The usefulness of Veno-Arterial Extracorporeal Membranous Oxygenation in Patients with Cardiogenic Shock.
Cardiogenic shock
Hemodynamics
Lactate
Myocardial infarction
VA ECMO
Journal
Open access Macedonian journal of medical sciences
ISSN: 1857-9655
Titre abrégé: Open Access Maced J Med Sci
Pays: North Macedonia
ID NLM: 101662294
Informations de publication
Date de publication:
15 Jun 2019
15 Jun 2019
Historique:
received:
17
04
2019
revised:
09
06
2019
accepted:
10
06
2019
entrez:
19
7
2019
pubmed:
19
7
2019
medline:
19
7
2019
Statut:
epublish
Résumé
Venoarterial extracorporeal membranous oxygenation is a form of temporary mechanical circulatory support that gets as a salvage technique in patients with cardiogenic shock, we intended to evaluate the effect of (VA ECMO) support on hemodynamics and lactate levels in patients with cardiogenic shock. The aim of our study is to detect the ability to introduce veno-arterial extracorporeal membranous oxygenation (VA ECMO) as a temporary extracorporeal life support system (ECLS) in our unit, demonstrate the role of ECMO in cardiogenic shock patients regarding improving hemodynamics and microcirculation, and demonstrate the complications and drawbacks in our first center experience regarding VA ECMO. This was a single-centre observational study that included 10 patients admitted with cardiogenic shock for which VA ECMO was used as mechanical circulatory support. The MAP increased after initiation of the support. It was 41.8 ± 9.3 mmHg and 59.5 ± 6.8 mmHg (P = 0.005). The use of VA ECMO support was associated with a statistically significant decrease in the base deficit (-10.6 ± 4.2 and -6.3 ± 7.4, P = 0.038). The serum lactate declined from 5.9 ± 3.5 mmoL/L to 0.6 ± 4.4 mmoL/L by the use of VA ECMO; a statistically significant change (P = 0.005). We concluded that VA ECMO as mechanical support for patients with cardiogenic shock might improve mean arterial blood pressure, base deficit and lactate clearance.
Sections du résumé
BACKGROUND
BACKGROUND
Venoarterial extracorporeal membranous oxygenation is a form of temporary mechanical circulatory support that gets as a salvage technique in patients with cardiogenic shock, we intended to evaluate the effect of (VA ECMO) support on hemodynamics and lactate levels in patients with cardiogenic shock.
AIM
OBJECTIVE
The aim of our study is to detect the ability to introduce veno-arterial extracorporeal membranous oxygenation (VA ECMO) as a temporary extracorporeal life support system (ECLS) in our unit, demonstrate the role of ECMO in cardiogenic shock patients regarding improving hemodynamics and microcirculation, and demonstrate the complications and drawbacks in our first center experience regarding VA ECMO.
MATERIAL AND METHODS
METHODS
This was a single-centre observational study that included 10 patients admitted with cardiogenic shock for which VA ECMO was used as mechanical circulatory support.
RESULTS
RESULTS
The MAP increased after initiation of the support. It was 41.8 ± 9.3 mmHg and 59.5 ± 6.8 mmHg (P = 0.005). The use of VA ECMO support was associated with a statistically significant decrease in the base deficit (-10.6 ± 4.2 and -6.3 ± 7.4, P = 0.038). The serum lactate declined from 5.9 ± 3.5 mmoL/L to 0.6 ± 4.4 mmoL/L by the use of VA ECMO; a statistically significant change (P = 0.005).
CONCLUSIONS
CONCLUSIONS
We concluded that VA ECMO as mechanical support for patients with cardiogenic shock might improve mean arterial blood pressure, base deficit and lactate clearance.
Identifiants
pubmed: 31316656
doi: 10.3889/oamjms.2019.547
pii: OAMJMS-7-1768
pmc: PMC6614275
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1768-1773Références
J Endovasc Ther. 2010 Feb;17(1):51-4
pubmed: 20199267
Artif Organs. 2010 Feb;34(2):E59-64
pubmed: 20420591
Crit Care Med. 2011 Jan;39(1):1-7
pubmed: 21057309
Arch Neurol. 2011 Dec;68(12):1543-9
pubmed: 21825216
J Crit Care. 2012 Oct;27(5):524.e7-14
pubmed: 22386227
Infect Control Hosp Epidemiol. 2013 Jan;34(1):24-30
pubmed: 23221189
Ann Vasc Surg. 2014 Jan;28(1):178-83
pubmed: 24064046
ASAIO J. 2013 Nov-Dec;59(6):554-7
pubmed: 24172260
Ann Thorac Surg. 2014 Feb;97(2):610-6
pubmed: 24210621
Int J Clin Pract. 2014 Apr;68(4):529-31
pubmed: 24674706
Crit Care Med. 2014 Sep;42(9):2075-82
pubmed: 24810530
J Thorac Cardiovasc Surg. 2015 May;149(5):1445-50
pubmed: 25534305
Intensive Care Med. 2015 May;41(5):902-5
pubmed: 25619488
Eur Heart J Acute Cardiovasc Care. 2015 Jun;4(3):278-97
pubmed: 25624526
J Am Coll Cardiol. 2015 May 19;65(19):e7-e26
pubmed: 25861963
Intensive Care Med. 2016 Mar;42(3):370-378
pubmed: 26825953
Sci Rep. 2016 Apr 01;6:23838
pubmed: 27032984
Crit Care Med. 2016 Nov;44(11):1974-1979
pubmed: 27322361
Eur J Heart Fail. 2016 Sep;18(9):1144-52
pubmed: 27594176
Crit Care. 2017 Mar 28;21(1):76
pubmed: 28347320